Thrombocytopenia secondary to linezolid administration: What is the risk? [5]

Clinical Infectious Diseases

Volumn 35, Issue 3, 2002, Pages 348-349

  Orrick, Joanne J ^a   Johns, Thomas ^a   Janelle, Jennifer ^b   Ramphal, Reuben ^b  

^a UNIVERSITY OF FLORIDA   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LINEZOLID;

HUMAN; INCIDENCE; LETTER; PRIORITY JOURNAL; RISK FACTOR; THROMBOCYTE COUNT; THROMBOCYTOPENIA;

ACETAMIDES; ANTI-INFECTIVE AGENTS; HUMANS; OXAZOLIDINONES; RISK FACTORS; THROMBOCYTOPENIA;

EID: 0036680631     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/341310     Document Type: Letter

References (2)

1. Thrombocytopenia associated with linezolid therapy